Search

Alphameprodine

Alphameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. … It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation, as well as itching, nausea, and respiratory depression.

Betameprodine

Betameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances. … It exerts physiological effects characteristic of opioids, such as analgesia, euphoria and sedation, as well as itching, nausea, and respiratory depression.

ASP-8731

Developed by Mitobridge, it is being investigated for the treatment of sickle cell disease.[L46093]

BEA-17

[L48330] It is under investigation for the treatment of glioblastoma.

INGN 225

INGN 225 is currently in Phase 1/2 trials in patients with small cell lung cancer and breast cancer. … INGN 225 is a therapeutic consisting of a cancer patient's own immune cells treated with an adenovector carrying the human p53 gene, Ad-p53.

Adakitug

HuMax-Inflam was also effective in reducing disease activity in palmoplantar pustulosis patients in a clinical study. … In pre-clinical studies, HuMax-Inflam has been shown to inhibit tumor growth in tumor models using primary human tumors in immunodeficient mice.

5alpha-androstane-3beta,17alpha-diol

It has been implicated as a regulator of gonadotropin secretion.

Moexiprilat

The active metabolite of the prodrug Moexipril.

Deuterium oxide

Lentinan